Esperion Therapeutics
ESPR
#6821
Rank
HK$3.47 B
Marketcap
HK$17.72
Share price
8.06%
Change (1 day)
149.40%
Change (1 year)

P/S ratio for Esperion Therapeutics (ESPR)

P/S ratio as of November 2024 (TTM): 1.61

According to Esperion Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -1.30. At the end of 2024 the company had a P/S ratio of 1.51.

P/S ratio history for Esperion Therapeutics from 2013 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20241.51-48.2%
20232.92-51.95%
20226.0856.69%
20213.8831.08%
20202.96-73.21%
201911.1
2018N/A
2017N/A
2016N/A
2015N/A
2014N/A
2013N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
9.66 499.93%๐Ÿ‡บ๐Ÿ‡ธ USA
4.64 188.31%๐Ÿ‡บ๐Ÿ‡ธ USA
2.72 68.97%๐Ÿ‡บ๐Ÿ‡ธ USA
6.57 308.20%๐Ÿ‡บ๐Ÿ‡ธ USA
7.21 347.48%๐Ÿ‡บ๐Ÿ‡ธ USA
126 7,728.95%๐Ÿ‡บ๐Ÿ‡ธ USA